GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (CHIX:COLOBc) » Definitions » PB Ratio

Coloplast AS (CHIX:COLOBC) PB Ratio : 9.96 (As of Jan. 19, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-01-19), Coloplast AS's share price is kr793.20. Coloplast AS's Book Value per Share for the quarter that ended in Sep. 2024 was kr79.62. Hence, Coloplast AS's PB Ratio of today is 9.96.

Good Sign:

Coloplast AS stock PB Ratio (=10.15) is close to 1-year low of 9.9

The historical rank and industry rank for Coloplast AS's PB Ratio or its related term are showing as below:

CHIX:COLOBc' s PB Ratio Range Over the Past 10 Years
Min: 9.06   Med: 24.48   Max: 38.02
Current: 10.15

During the past 13 years, Coloplast AS's highest PB Ratio was 38.02. The lowest was 9.06. And the median was 24.48.

CHIX:COLOBc's PB Ratio is ranked worse than
91.61% of 787 companies
in the Medical Devices & Instruments industry
Industry Median: 2.29 vs CHIX:COLOBc: 10.15

During the past 12 months, Coloplast AS's average Book Value Per Share Growth Rate was 3.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 27.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 21.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 11.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Coloplast AS was 30.30% per year. The lowest was -9.40% per year. And the median was 9.85% per year.

Back to Basics: PB Ratio


Coloplast AS PB Ratio Historical Data

The historical data trend for Coloplast AS's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS PB Ratio Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.85 26.33 19.37 10.09 10.98

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.09 11.52 12.99 11.26 10.98

Competitive Comparison of Coloplast AS's PB Ratio

For the Medical Instruments & Supplies subindustry, Coloplast AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's PB Ratio falls into.



Coloplast AS PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Coloplast AS's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=793.20/79.624
=9.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Coloplast AS  (CHIX:COLOBc) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Coloplast AS PB Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast AS's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines